/Investor DB

Tin Alley Ventures — Full Portfolio

16 tracked investments · listed companies and verified rows first

Apromoreapromore.cominAug 2024

Apromore provides process mining software that enables businesses to gain digital transparency into their operational processes and reduce implementation risks.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSaaSMelbourne, AU

Prof. Marcello La Rosa(Chief Executive Officer & Co-Founder)Prof. Marlon Dumas(Chief Product Officer & Co-Founder)

Co-investorsSalesforce Ventures

Eigen Innovationseigen.ioinAug 2026 · $20M

Eigen Innovations develops AI vision software and solutions for manufacturing enterprises to enable digital transformation and improve operational efficiency.

Advanced ManufacturingAI & Machine LearningEnterprise SoftwareHardwareFredericton

SCOTT EVERETT(Director)Paul Scherer(Founder)inRICHARD JONES(Executive Officer, Director)Erin Barrett(Chief Executive Officer)in

BoardBILL BARRETT(Director, Promoter)RICKY DUBAY(Director)

Co-investorsCeltic House Asia PartnersEast Valley VenturesFirst Angel Network Association (FAN)Momenta VenturesAGI HOUSE VENTURESAramco Ventures+9 more

Official Partnerofficialpartner.work

A creative services agency offering web development, design, animations, copywriting, and user experience consulting for digital projects.

Developer Tools

Justin Donais(Founder, CITRONA STUDIO)Tyler Leonard(Founder, BOUNDARY)Kelly Bernard(Founder, GLITCH&GRIT)

Co-investorsMighty Partners

Porous Laneporouslane.com.auinOct 2024

Porous Lane develops permeable pavement systems made from recycled tyres and other waste materials for sustainable infrastructure.

Circular EconomyCleantechConstruction TechNew MaterialsMelbourne, AU

Dr. Amir Mehdizadeh(Co-founder and Managing Director)Associate Prof. Mahdi Disfani(Research & Development)Bradley Camgoz Posselt(CEO)in

Proxima Bioproximabio.com.au

Proxima Bio is an early-stage biotechnology company developing protein degradation technology to target previously undruggable proteins for treatment of autoimmune conditions and cancers.

BiotechHealthtechMedical DevicesMelbourne, AU

Jase(Co-founder)Jon(Co-founder)John McFarland(Executive Officer)Zachary Carpenter(Executive Officer, Director)

BoardJason Pontin(Director)inAlex Gasner(Director)

Co-investorsTenmileDCVC (Data Collective)

Silicon Quantum Computingsqc.comin

Silicon Quantum Computing develops fault-tolerant quantum processors using atomic-scale manufacturing techniques, targeting applications in AI acceleration, quantum simulation, and quantum computing.

AI & Machine LearningDeep TechHardwareNew MaterialsQuantum Computing

Michelle Simmons(Professor)

Co-investorsTitanium VenturesUNSW

Synchronsynchron.comin𝕏May 2021

Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.

BiotechDeep TechMedical DevicesCampbell, US

Thomas James Oxley(Executive Officer, Director)Nicholas Opie(Founder)inThomas Oxley(Founder)inTom Oxley(Founder)

BoardRahul Sharma(Director)Alex Morgan(Director)in

Co-investorsAlumni VenturesARCH Venture PartnersForepont Capital PartnersID8 InvestmentsIn-Q-TelK2 Global+15 more

Tanarratanarra.comin

Tanarra is an investment firm managing over A$2.75 billion in assets on behalf of superannuation funds, financial institutions, and family offices.

John Wylie(Founder & Chief Executive Officer)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Cell BauhausExternaGallant BioI14Intelligent SiliconKronusNeurala BiosciencesTwin 1 Ai

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.